134 related articles for article (PubMed ID: 16242244)
1. Impulsivity, inhibition and negative priming in ecstasy users.
Dafters RI
Addict Behav; 2006 Aug; 31(8):1436-41. PubMed ID: 16242244
[TBL] [Abstract][Full Text] [Related]
2. Chronic ecstasy (MDMA) use is associated with deficits in task-switching but not inhibition or memory updating executive functions.
Dafters RI
Drug Alcohol Depend; 2006 Jun; 83(2):181-4. PubMed ID: 16316723
[TBL] [Abstract][Full Text] [Related]
3. Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use.
Butler GK; Montgomery AM
Drug Alcohol Depend; 2004 Oct; 76(1):55-62. PubMed ID: 15380289
[TBL] [Abstract][Full Text] [Related]
4. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
Morgan MJ; McFie L; Fleetwood H; Robinson JA
Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
[TBL] [Abstract][Full Text] [Related]
5. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
[TBL] [Abstract][Full Text] [Related]
6. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
Parrott AC
J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
[TBL] [Abstract][Full Text] [Related]
7. Evidence for executive deficits among users of MDMA (Ecstasy).
Fisk JE; Montgomery C; Murphy P; Wareing M
Br J Psychol; 2004 Nov; 95(Pt 4):457-66. PubMed ID: 15527532
[TBL] [Abstract][Full Text] [Related]
8. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
Reay JL; Hamilton C; Kennedy DO; Scholey AB
J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
[TBL] [Abstract][Full Text] [Related]
9. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
10. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
Gouzoulis-Mayfrank E; Thimm B; Rezk M; Hensen G; Daumann J
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
[TBL] [Abstract][Full Text] [Related]
11. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
Milani RM; Parrott AC; Schifano F; Turner JJ
Hum Psychopharmacol; 2005 Jun; 20(4):249-61. PubMed ID: 15816011
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of MDMA (Ecstasy) on the human central nervous system revealed by visual evoked potentials.
Casco C; Forcella M; Beretta G; Grieco A; Campana G
Addict Biol; 2005 Jun; 10(2):187-95. PubMed ID: 16191672
[TBL] [Abstract][Full Text] [Related]
13. Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.
Bedi G; Redman J
Psychol Med; 2008 Sep; 38(9):1319-30. PubMed ID: 18226286
[TBL] [Abstract][Full Text] [Related]
14. Evidence of increased activation underlying cognitive control in ecstasy and cannabis users.
Roberts GM; Garavan H
Neuroimage; 2010 Aug; 52(2):429-35. PubMed ID: 20417713
[TBL] [Abstract][Full Text] [Related]
15. Impulsivity differences in recreational cannabis users and binge drinkers in a university population.
Moreno M; Estevez AF; Zaldivar F; Montes JM; Gutiérrez-Ferre VE; Esteban L; Sánchez-Santed F; Flores P
Drug Alcohol Depend; 2012 Aug; 124(3):355-62. PubMed ID: 22425410
[TBL] [Abstract][Full Text] [Related]
16. Learning and memory deficits in ecstasy users and their neural correlates during a face-learning task.
Roberts GM; Nestor L; Garavan H
Brain Res; 2009 Oct; 1292():71-81. PubMed ID: 19631624
[TBL] [Abstract][Full Text] [Related]
17. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
Quednow BB; Jessen F; Kuhn KU; Maier W; Daum I; Wagner M
J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
[TBL] [Abstract][Full Text] [Related]
18. Evidence for selective executive function deficits in ecstasy/polydrug users.
Fisk JE; Montgomery C
J Psychopharmacol; 2009 Jan; 23(1):40-50. PubMed ID: 18515461
[TBL] [Abstract][Full Text] [Related]
19. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
Soar K; Turner JJ; Parrott AC
J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
[TBL] [Abstract][Full Text] [Related]
20. Self-reports of executive dysfunction in current ecstasy/polydrug Users.
Hadjiefthyvoulou F; Fisk JE; Montgomery C; Bridges N
Cogn Behav Neurol; 2012 Sep; 25(3):128-38. PubMed ID: 22960437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
